Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Transmembrane protein 151A (TMEM151A) is an evolutionarily conserved, multi-pass transmembrane protein encoded by the TMEM151A gene, located on chromosome 11q13.2. It comprises 468 amino acids and contains three predicted transmembrane domains with most of its structure oriented toward the cytoplasm. TMEM151A is an integral component of the endoplasmic reticulum membrane in humans and other vertebrates[4][7]. Its precise molecular function remains unknown, but findings from both genetic and functional studies implicate it in the pathogenesis of paroxysmal kinesigenic dyskinesia, a neurologic disorder characterized by involuntary movements[1][5][6][8]. While some evidence suggests it may have roles in ion channel activity or intracellular calcium signaling, this remains to be fully defined[7]. No established drug interactions, mechanisms of action, biomarkers, or therapeutic applications are documented for TMEM151A at present.
None known
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Transmembrane protein 151A (TMEM151A).